Evid Based Nurs 2:52 doi:10.1136/ebn.2.2.52
  • Treatment

HRT did not reduce coronary events in postmenopausal women with existing heart disease

 Question Can oestrogen plus progestin prevent recurrent non-fatal myocardial infarction (MI) and coronary heart disease (CHD) mortality in postmenopausal women with established CHD?


Randomised, double blind, placebo controlled trial with mean follow up of 4.1 years (Heart and Estrogen/progestin Replacement Study [HERS]).


20 outpatient and community settings in the US.


2763 postmenopausal women between 44 and 79 years of age (mean age 67 y, 89% white) with established CHD who had not had a hysterectomy. Exclusion criteria were CHD event ≤6 months before study; sex hormone use ≤3 months before study; history of breast cancer, deep vein thrombosis, pulmonary embolism, hyperplasia, or endometrial cancer; abnormal mammogram or Papanicolaou test; increased serum triglyceride or serum aspartate aminotransferase concentrations; geographic inaccessibility; other fatal disease; congestive heart failure; alcoholism or drug abuse; uncontrolled hypertension or diabetes; participation in another study; <80% compliance with prestudy placebo; or intolerance to hormone therapy. Follow up was 100%. …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article